Moreover, using KS biopsies we show that COX-2 is overexpressed in KSHV-infected cells of KS lesions, defining COX-2 as a potential target for preventing and treating KSHV-oncogenesis. The gene discussed is PTGS2; the disease is Kaposi's sarcoma.